Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Diarrhea × Cefpodoxime × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Solid Tumors 1 Solid Tumor 1 Neuroblastoma 1 Neoplasms 1 Diarrhea 1

Interventions

Irinotecan 3 Theophylline 1 Temozolomide 1 Oxaliplatin 1 Loperamide 1 Leucovorin 1 Fluorouracil 1 Fecal Microbiota Transplantation 1 Erlotinib Hydrochloride 1 Celecoxib 1 Cefpodoxime 1 Cefixime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00143533 2017-04-26

Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors

St. Jude Children's Research Hospital

Phase 1 Completed

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡